2M73
| |
2M74
| 1H, 13C and 15N assignments of the four N-terminal domains of human fibrillin-1 | Descriptor: | Fibrillin-1 | Authors: | Yadin, D.A, Robertson, I.B, Jensen, S.A, Handford, P.A, Redfield, C. | Deposit date: | 2013-04-17 | Release date: | 2013-09-25 | Last modified: | 2024-10-30 | Method: | SOLUTION NMR | Cite: | Structure of the Fibrillin-1 N-Terminal Domains Suggests that Heparan Sulfate Regulates the Early Stages of Microfibril Assembly. Structure, 21, 2013
|
|
2M75
| |
2M76
| |
2M77
| [Asp2]RTD-1 | Descriptor: | [Asp2]RTD-1 | Authors: | Conibear, A.C, Bochen, A, Rosengren, K, Kessler, H, Craik, D.J. | Deposit date: | 2013-04-18 | Release date: | 2014-02-05 | Last modified: | 2023-06-14 | Method: | SOLUTION NMR | Cite: | The Cyclic Cystine Ladder of Theta-Defensins as a Stable, Bifunctional Scaffold: A Proof-of-Concept Study Using the Integrin-Binding RGD Motif Chembiochem, 15, 2014
|
|
2M78
| [Asp11]RTD-1 | Descriptor: | [Asp11]RTD-1 | Authors: | Conibear, A.C, Bochen, A, Rosengren, K, Kessler, H, Craik, D.J. | Deposit date: | 2013-04-19 | Release date: | 2014-02-05 | Last modified: | 2023-06-14 | Method: | SOLUTION NMR | Cite: | The Cyclic Cystine Ladder of Theta-Defensins as a Stable, Bifunctional Scaffold: A Proof-of-Concept Study Using the Integrin-Binding RGD Motif Chembiochem, 15, 2014
|
|
2M79
| [Asp2,11]RTD-1 | Descriptor: | [Asp2,11]RTD-1 | Authors: | Conibear, A.C, Bochen, A, Rosengren, K, Kessler, H, Craik, D.J. | Deposit date: | 2013-04-19 | Release date: | 2014-02-05 | Last modified: | 2024-11-13 | Method: | SOLUTION NMR | Cite: | The Cyclic Cystine Ladder of Theta-Defensins as a Stable, Bifunctional Scaffold: A Proof-of-Concept Study Using the Integrin-Binding RGD Motif Chembiochem, 15, 2014
|
|
2M7A
| |
2M7B
| |
2M7C
| |
2M7D
| |
2M7E
| |
2M7F
| |
2M7G
| |
2M7H
| |
2M7I
| |
2M7J
| |
2M7K
| |
2M7L
| |
2M7M
| N-terminal domain of EhCaBP1 structure | Descriptor: | CALCIUM ION, Calcium-binding protein | Authors: | Chary, K.V, Rout, A.K, Patel, S, Bhattacharya, A. | Deposit date: | 2013-04-26 | Release date: | 2013-06-19 | Last modified: | 2024-05-15 | Method: | SOLUTION NMR | Cite: | Functional Manipulation of a Calcium-binding Protein from Entamoeba histolytica Guided by Paramagnetic NMR. J.Biol.Chem., 288, 2013
|
|
2M7N
| C-terminal structure of (Y81F)-EhCaBP1 | Descriptor: | CALCIUM ION, Calcium-binding protein | Authors: | Chary, K.V, Rout, A.K, Patel, S, Bhattacharya, A. | Deposit date: | 2013-04-26 | Release date: | 2013-06-19 | Last modified: | 2024-05-15 | Method: | SOLUTION NMR | Cite: | Functional Manipulation of a Calcium-binding Protein from Entamoeba histolytica Guided by Paramagnetic NMR. J.Biol.Chem., 288, 2013
|
|
2M7O
| |
2M7P
| RXFP1 utilises hydrophobic moieties on a signalling surface of the LDLa module to mediate receptor activation | Descriptor: | CALCIUM ION, Low-density lipoprotein receptor, Relaxin receptor 1 | Authors: | Kong, R.CK, Petrie, E.J, Mohanty, B, Ling, J, Lee, J.C.Y, Gooley, P.R, Bathgate, R.A.D. | Deposit date: | 2013-04-29 | Release date: | 2013-08-14 | Last modified: | 2024-11-13 | Method: | SOLUTION NMR | Cite: | The relaxin receptor (RXFP1) utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activation. J.Biol.Chem., 288, 2013
|
|
2M7Q
| Solution structure of TAX1BP1 UBZ1+2 | Descriptor: | Tax1-binding protein 1, ZINC ION | Authors: | Ceregido, M.A, Spinola Amilibia, M, Buts, L, Bravo, J, van Nuland, N.A.J. | Deposit date: | 2013-04-29 | Release date: | 2013-12-04 | Last modified: | 2024-05-15 | Method: | SOLUTION NMR | Cite: | The structure of TAX1BP1 UBZ1+2 provides insight into target specificity and adaptability. J.Mol.Biol., 426, 2014
|
|
2M7R
| Nmda receptor antagonist, conantokin bk-b, nmr, 20 structure | Descriptor: | CONANTOKIN BK-B | Authors: | Curtice, K.J, Platt, R.J, Skalicky, J.J, Horvath, M.P, Twede, V.D. | Deposit date: | 2013-04-29 | Release date: | 2014-02-19 | Last modified: | 2023-06-14 | Method: | SOLUTION NMR | Cite: | From molecular phylogeny towards differentiating pharmacology for NMDA receptor subtypes. Toxicon, 81C, 2014
|
|